tranexamic acid has been researched along with Invasiveness, Neoplasm in 2 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Tranexamic acid (TA) is an inhibitor of plasminogen activation commonly used in surgery." | 1.35 | Tranexamic acid can inhibit tongue squamous cell carcinoma invasion in vitro. ( Salo, T; Sorsa, T; Suojanen, J, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wen, KC | 1 |
| Sung, PL | 1 |
| Chou, YT | 1 |
| Pan, CM | 1 |
| Wang, PH | 1 |
| Lee, OK | 1 |
| Wu, CW | 1 |
| Suojanen, J | 1 |
| Sorsa, T | 1 |
| Salo, T | 1 |
2 other studies available for tranexamic acid and Invasiveness, Neoplasm
| Article | Year |
|---|---|
The role of EpCAM in tumor progression and the clinical prognosis of endometrial carcinoma.
Topics: Animals; Antifibrinolytic Agents; Cell Line, Tumor; Disease Progression; Down-Regulation; Endometria | 2018 |
Tranexamic acid can inhibit tongue squamous cell carcinoma invasion in vitro.
Topics: Antifibrinolytic Agents; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Movement; Enzyme Inhi | 2009 |